What is the power of evidence recommending routine probiotics for necrotizing enterocolitis prevention in preterm infants?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 3, 2011, Pages 302-306

  Mihatsch, Walter A ^a  

^a 74523 Schwäbisch Hall ^*  (Germany)

Author keywords

necrotizing enterocolitis; preterm neonate; probiotics

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEEDING; HUMAN; INFANT MORTALITY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SACCHAROMYCES BOULARDII; SEPSIS; STREPTOCOCCUS THERMOPHILUS;

DIETARY SUPPLEMENTS; ENTEROCOLITIS, NECROTIZING; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL TRACT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PROBIOTICS;

EID: 79954993024     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283454e78     Document Type: Article

References (59)

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255-264.
2. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187:1-7.
3. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33:179-201 (Pubitemid 16135483)
4. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006; 368:1271-1283. (Pubitemid 44485800)
5. Luoto R, Matomaki J, Isolauri E, Lehtonen L. Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG. Acta Paediatr 2010; 99:1135-1138.
6. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125:921-930.
7. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J. Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010; 125:1068-1070.
8. Tarnow-Mordi W, Wilkinson D, Trivedi A, et al. ESPGHAN Commentary and evidence that probiotics substantially reduce all-cause mortality and necrotizing enterocolitis in preterm infants. J Pediatr Gastroenterol Nutr 2010; 50:694-695.
9. Mihatsch WA, Pohlandt F. Should probiotics already be recommended as standard clinical care for preterm infants with birth weights below 1500 g? Klin Pä diatr 2010; 222:282-283.
10. Beattie LM, Hansen R, Barclay AR. Probiotics for preterm infants: confounding features warrant caution. Pediatrics 2010; 126:e742-e743; author reply e743-e745.
11. Neu J, Shuster J. Nonadministration of routine probiotics unethical-really? Pediatrics 2010; 126:e740-e741; author reply e743-e745.
12. Garland SM, Jacobs SE, Tobin JM, et al. A cautionary note on instituting probiotics into routine clinical care for premature infants. Pediatrics 2010; 126:e741-e742; author reply e743-e745.
13. Szajewska H, Shamir R. Is a meta-analytical approach appropriate to assess the efficacy of probiotics? Pediatrics 2010. [e-letter].
14. Neu J. Routine probiotics for premature infants: let's be careful! J Pediatr 2011. [Epub ahead of print]
15. Soll RF. Probiotics: are we ready for routine use? Pediatrics 2010; 125:1071-1072.
16. Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009; 3:944-954.
17. Mshvildadze M, Neu J, Shuster J, et al. Intestinal microbial ecology in premature infants assessed with nonculture-based techniques. J Pediatr 2010; 156:20-25.
18. Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123:58-66.
19. Lafeber HN, Westerbeek EA, van den Berg A, et al. Nutritional factors influencing infections in preterm infants. J Nutr 2008; 138:1813S-1817S.
20. Butel MJ, Roland N, Hibert A, et al. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 1998; 47:391-399. (Pubitemid 28191042)
21. Siggers RH, Siggers J, Boye M, et al. Early administration of probiotics alters bacterial colonization and limits diet-induced gut dysfunction and severity of necrotizing enterocolitis in preterm pigs. J Nutr 2008; 138:1437-1444.
22. Caplan MS, Miller-Catchpole R, Kaup S, et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999; 117:577-583. (Pubitemid 29409243)
23. Copeland DR, McVay MR, Dassinger MS, et al. Probiotic fortified diet reduces bacterial colonization and translocation in a long-term neonatal rabbit model. J Pediatr Surg 2009; 44:1061-1064; discussion 1054.
24. McVay MR, Boneti C, Habib CM, et al. Formula fortified with live probiotic culture reduces pulmonary and gastrointestinal bacterial colonization and translocation in a newborn animal model. J Pediatr Surg 2008; 43:25-29; discussion 29.
25. Akisu M, Baka M, Yalaz M, et al. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Eur J Pediatr Surg 2003; 13:319-323. (Pubitemid 37462367)
26. Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009; 297:G940-G949
27. Caplan MS. Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis. J Perinatol 2009; 29 (Suppl. 2):S2-S6.
28. Alfaleh K, Anabrees J, Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 2009; 97:93-99.
29. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008:CD005496.
30. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birth weight: a systematic review of randomised controlled trials. Lancet 2007; 369:1614-1620. (Pubitemid 46710124)
31. Barclay AR, Stenson B, Simpson JH, et al. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007; 45:569-576. (Pubitemid 350307143)
32. Mshvildadze M, Neu J. Probiotics and prevention of necrotizing enterocolitis. Early Hum Dev 2009; 85:S71-S74.
33. Mihatsch WA, Pohlandt F. Probiotika-Eine Routinetherapie fü r Frü hgeborene? Was beweisen die bisherigen Studien? Kinder Jugendmedizin 2010; 10:21-32.
34. Braegger C, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2011; 52:238-250.
35. Thomas DW, Greer FR. Probiotics and prebiotics in pediatrics. Pediatrics 2010; 126:1217-1231.
36. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122:693-700.
37. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115:1-4.
38. Awad H, Mokhtar H, Imam SS, et al. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci 2010; 13:253-262.
39. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147:192-196. (Pubitemid 41207832)
40. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2010; 93:81-86.
41. Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003; 74:89-96. (Pubitemid 37315841)
42. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. a prospective double-blind study. Biol Neonate 2002; 82:103-108.
43. Chou IC, Kuo HT, Chang JS, et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatr 2010; 156:393-396.
44. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006; 42:1735-1742. (Pubitemid 43839439)
45. Mihatsch WA, Vossbeck S, Eikmanns B, et al. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010; 98:156-163.
46. Mohan R, Koebnick C, Schildt J, et al. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol 2006; 44:4025-4031. (Pubitemid 44737246)
47. Mohan R, Koebnick C, Schildt J, et al. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res 2008; 64:418-422.
48. Rougé C, Piloquet H, Butel MJ, et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebocontrolled trial. Am J Clin Nutr 2009; 89:1828-1835.
49. Samanta M, Sarkar M, Ghosh P, et al. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55:128-131.
50. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 2007; 83:575-579. (Pubitemid 47380129)
51. Petrof EO. Probiotics and gastrointestinal disease: clinical evidence and basic science. Antiinflamm Antiallergy Agents Med Chem 2009; 8:260-269.
52. Kelly P, Maguire PB, Bennett M, et al. Correlation of probiotic Lactobacillus salivarius growth phase with its cell wall-associated proteome. FEMS Microbiol Lett 2005; 252:153-159. (Pubitemid 41446406)
53. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebocontrolled trial. J Allergy Clin Immunol 2008; 122:788-794.
54. Canani RB, Cirillo P, Terrin G, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007; 335:340.
55. Oxford Centre for Evidence-based Medicine-Levels of Evidence on World Wide Web URL. http://www.cebm.net/?o=1025.
56. Higgins JPT, Altman DG. Assessing the risk of bias in included studies. In: Higgins JPT, Green S: The Cochrane Collaboration, editors. Cochrane handbook for systematic reviews of interventions, Version 5.0.2.; 2009. [Vol. updated September 2009].
57. CRD. Systematic Reviews. In: Centre for Reviews and Dissemination. CRD's guidance for undertaking reviews in healthcare. . York: York Publishing Services Ltd; 2009.
58. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134:663-694. (Pubitemid 32322245)
59. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152:726-732.